Loading...
Hyderabad's Pharma Capital Status Meets Clinical Skincare — Your Exclusive Franchise Territory Awaits
Hyderabad's dual identity as a pharma manufacturing hub and booming IT metro makes it exceptionally fertile ground for Barekyne's B2B model. The city's established pharma distributor networks can be rapidly onboarded, and the high-income Banjara Hills–Jubilee Hills corridor drives strong premium clinic demand.
Hyderabad's pharma ecosystem gives Barekyne franchise partners a unique advantage: many existing distributors already have established logistics networks and chemist/clinic relationships that dramatically reduce market-entry time.
Territories marked open are available for exclusive franchise allocation. First-confirmed partner takes the territory.
Not 200 generic products. A focused, high-velocity clinical range where every SKU has a dermatologist prescription rationale and a defensible active concentration.
20% Vit C · 2% Niacinamide · Hyaluronic Acid
Indication: Hyperpigmentation · PIH · Dull Skin
Tyrosinase inhibition + melanosome transfer blockade
Physical + Chemical dual-filter system
Indication: Photoprotection · PIH Prevention
Zero white cast on Fitzpatrick III–VI · Sweat resistant
Glycolic Acid · Salicylic Acid · Vitamin C · Cica
Indication: Acne · Oily Skin · Comedonal Acne
AHA + BHA dual exfoliation with anti-inflammatory modulation
Kojic Acid Dipalmitate · Niacinamide · Alpha Arbutin
Indication: Dark Spots · Melasma · Post-Inflammatory Hyperpigmentation
Triple-pathway overnight depigmentation — synthesis, transfer & expression
Vitamin C · Dermawhite™ Technology
Indication: Year-round Hydration · Brightening
Advanced depigmentation technology · 100ml
Every Barekyne formulation complies strictly with the Drugs and Cosmetics Act, 1940. Manufacturing is conducted exclusively in WHO-GMP and ISO 9001:2015 certified facilities to ensure pharmaceutical-grade consistency and safety.
By bypassing third-party super stockists and traditional distributors, we guarantee direct-from-manufacturer supply lines, enabling industry-leading ROI on B2B skincare procurement.
Once a territory is allocated, it is closed. Exclusive monopoly rights are granted to the first confirmed franchise partner in each district. Fill the form below — our B2B team reviews applications within 48 hours.